Breaking News Instant updates and real-time market news.

2021-02-17 16:07:08 MTEM Molecular Templates $13.65 / -0.1 (-0.73%) 16:07 02/17/21 02/17 16:07 02/17/21 16:07	Molecular Templates files to sell common stock, no amount given Molecular intends to use the net proceeds from the offering, together with its existing cash and cash equivalents, to fund: its Phase II clinical studies for MT-3724 and/or development of other CD20-targeted molecules; its ongoing Phase I clinical study of MT-5111; its share of development expenses in its CD38 collaboration with Takeda; its PD-L1 program (including its anticipated upcoming Phase I clinical study for MT-6402); further preclinical development and drug discovery activities in its other programs; and for working capital and general corporate purposes. BofA Securities, Cowen, Evercore ISI and Barclays are acting as joint book-running managers for the offering.	01 Mar
MTEM Molecular Templates $13.65 / -0.1 (-0.73%) 02/01/21 UBS Molecular Templates initiated with a Neutral at UBS 09/08/20 Jefferies Molecular Templates initiated with a Buy at Jefferies 08/07/20 Molecular Templates files $300M mixed securities shelf 05/12/20 Oppenheimer Molecular Templates price target raised to $22 from $16 at Oppenheimer

2021-02-17 16:07:08

MTEM

Molecular Templates

$13.65 / -0.1 (-0.73%)

16:07

02/17/21

02/17

16:07

02/17/21

16:07

Molecular Templates files to sell common stock, no amount given

Molecular intends to use the net proceeds from the offering, together with its existing cash and cash equivalents, to fund: its Phase II clinical studies for MT-3724 and/or development of other CD20-targeted molecules; its ongoing Phase I clinical study of MT-5111; its share of development expenses in its CD38 collaboration with Takeda; its PD-L1 program (including its anticipated upcoming Phase I clinical study for MT-6402); further preclinical development and drug discovery activities in its other programs; and for working capital and general corporate purposes. BofA Securities, Cowen, Evercore ISI and Barclays are acting as joint book-running managers for the offering.

01
Mar

MTEM Molecular Templates

$13.65 / -0.1 (-0.73%)

02/01/21 UBS: Molecular Templates initiated with a Neutral at UBS

09/08/20 Jefferies: Molecular Templates initiated with a Buy at Jefferies

08/07/20: Molecular Templates files $300M mixed securities shelf

05/12/20 Oppenheimer: Molecular Templates price target raised to $22 from $16 at Oppenheimer

TODAY'S FREE FLY STORIES

Options	AgEagle Aerial Systems options imply 17.7% move in share price post-earnings » 15:04 03/05/21 03/05 15:04 03/05/21 15:04 UAVS Ageagle Aerial Systems $5.61 / -0.4 (-6.66%) Pre-earnings options… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Periodicals On The Fly Options UAVS Ageagle Aerial Systems $5.61 / -0.4 (-6.66%) 02/19/21 Ageagle says short seller report contained 'false, inaccurate' information 02/16/21 Ageagle Aerial Systems, Valqari piloting on-demand drone delivery of food 01/27/21 Ageagle Aerial Systems to acquire MicaSense for $23M 01/12/21 Ageagle Aerial Systems says State of Iowa chooses HempOverview platform UAVS Ageagle Aerial Systems $5.61 / -0.4 (-6.66%) 02/18/21 Ageagle Aerial Systems called 'pump and dump scheme' by Bonitas Research UAVS Ageagle Aerial Systems $5.61 / -0.4 (-6.66%) 02/18/21 Fly Intel: Wall Street's top stories for Thursday UAVS Ageagle Aerial Systems $5.61 / -0.4 (-6.66%) 02/19/21 AgEagle Aerial Systems Inc options imply 32.1% move in share price post-earnings 02/18/21 AgEagle Aerial Systems Inc put volume heavy and directionally bearish 02/03/21 new option listings on February 3rd
Periodicals	Ford dismisses ITC criticism over SK Innovation battery deals, Reuters reports » 15:01 03/05/21 03/05 15:01 03/05/21 15:01 F Ford $12.15 / +0.22 (+1.84%) Ford rejected criticism… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options F Ford $12.15 / +0.22 (+1.84%) 03/03/21 Ford reports February U.S. sales down 14.1% to 163,520 vehicles 02/24/21 Ford up 1% in pre-market trading after yesterday's USPS win by Oshkosh 02/23/21 Workhorse Group shares plunge after rival Oshkosh wins USPS deal 02/22/21 Ford issues recalls in North America for F-Series and Super Duty vehicles F Ford $12.15 / +0.22 (+1.84%) 03/03/21 Morgan Stanley Mustang Mach-E took major Tesla EV share in February, says Morgan Stanley 02/24/21 Roth Capital Roth cuts Workhorse target to $15 after 'highly unusual' contract loss 02/16/21 Wedbush Wedbush expects Apple to announce formal EV partnership in 2021 02/09/21 Fly Intel: Top five analyst upgrades F Ford $12.15 / +0.22 (+1.84%) 02/04/21 Ford reports Q4 adjusted EPS 34c, consensus (7c) 02/04/21 Notable companies reporting after market close 10/28/20 Ford sees temporarily lower F-150 wholesale shipments in Q4 10/28/20 Ford reports Q3 adjusted EBIT $3.6B F Ford $12.15 / +0.22 (+1.84%) 03/04/21 Ford quietly starts making new 'C' pickup in Mexico, CNBC reports 02/24/21 Ford may not have a piece of Oshkosh-USPS contract, Detroit Free Press reports 02/24/21 Biden to address chip shortages with executive action, WSJ reports 02/18/21 Ford shutters North American facilities amid inclement weather, Reuters says F Ford $12.15 / +0.22 (+1.84%) 02/27/21 Charged: Tesla temporarily halts Model 3 line at CA plant 02/24/21 Workhorse plunges, asks USPS for more info after NGDV deal goes to Oshkosh 02/20/21 Charged: Analyst sees Apple announcing EV partnership in 2021 02/09/21 Twilio, Baidu upgrades among today's top calls on Wall Street F Ford $12.15 / +0.22 (+1.84%) 03/02/21 Ford call volume above normal and directionally bullish 02/24/21 Ford call volume above normal and directionally bullish 02/05/21 Notable open interest changes for February 5th 02/04/21 Ford options imply 13.3% move in share price post-earnings
Recommendations	Taylor Wimpey price target raised to 195 GBp from 170 GBp at Barclays » 14:59 03/05/21 03/05 14:59 03/05/21 14:59 TWODF Taylor Wimpey $0.00 / + (+0.00%) Barclays analyst Gavin… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research TWODF Taylor Wimpey $0.00 / + (+0.00%) 03/04/21 Morgan Stanley Taylor Wimpey price target raised to 195 GBp from 180 GBp at Morgan Stanley 03/03/21 Credit Suisse Taylor Wimpey price target raised to 212 GBp from 205 GBp at Credit Suisse 02/08/21 Jefferies Taylor Wimpey upgraded to Buy from Hold at Jefferies 02/03/21 Barclays Taylor Wimpey upgraded to Overweight from Equal Weight at Barclays
Recommendations	Schroders price target raised to 3,430 GBp from 3,400 GBp at Barclays » 14:58 03/05/21 03/05 14:58 03/05/21 14:58 SHNWF Schroders $0.00 / + (+0.00%) Barclays analyst Michael… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research SHNWF Schroders $0.00 / + (+0.00%) 14:41 Today Credit Suisse Schroders price target raised to 3,270 GBp from 3,100 GBp at Credit Suisse 14:31 Today JPMorgan Schroders price target raised to 3,400 GBp from 3,375 GBp at JPMorgan 14:02 Today UBS Schroders price target raised to 4,100 GBp from 3,950 GBp at UBS 02/26/21 Morgan Stanley Schroders upgraded to Equal Weight from Underweight at Morgan Stanley
Recommendations	Qinetiq price target raised to 406 GBp from 380 GBp at Barclays » 14:57 03/05/21 03/05 14:57 03/05/21 14:57 QNTQF Qinetiq $0.00 / + (+0.00%) Barclays analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research QNTQF Qinetiq $0.00 / + (+0.00%) 12/03/20 Luna Innovations acquires OptaSense for GBP 29M in cash QNTQF Qinetiq $0.00 / + (+0.00%) 01/07/21 JPMorgan Qinetiq price target raised to 325 GBp from 310 GBp at JPMorgan 12/18/20 Berenberg Qinetiq price target raised to 375 GBp from 355 GBp at Berenberg 12/11/20 UBS Qinetiq upgraded to Buy from Neutral at UBS 11/13/20 Barclays Qinetiq price target raised to 380 GBp from 360 GBp at Barclays

Periodicals	Robinhood picks Nasdaq for eventual IPO, CNBC reports » 14:57 03/05/21 03/05 14:57 03/05/21 14:57 HOOD Robinhood $0.00 / + (+0.00%) , NDAQ Nasdaq $144.20 / +6.15 (+4.45%) Robinhood has chosen the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options HOOD NDAQ HOOD Robinhood $0.00 / + (+0.00%) 01/29/21 New class action against Robinhood alleges brokerage 'switched sides' 01/29/21 Robinhood to allow 'limited buys' on restricted stocks starting Friday 12/17/20 Robinhood pays $65M to settle SEC charges over misleading customers NDAQ Nasdaq $144.20 / +6.15 (+4.45%) 02/08/21 Nasdaq gets Investment Canada Act approval for Verafin, acquisition 02/02/21 Tradeweb Markets to acquire Nasdaq fixed income trade platform for $190M 02/02/21 Nasdaq to sell U.S. fixed income business to Tradeweb Markets 01/27/21 Nasdaq sees 2021 non-GAAP tax rate 25%-27% HOOD NDAQ HOOD Robinhood $0.00 / + (+0.00%) NDAQ Nasdaq $144.20 / +6.15 (+4.45%) 01/29/21 Citi Nasdaq price target raised to $147 from $144 at Citi 01/28/21 Barclays Nasdaq price target raised to $160 from $155 at Barclays 01/19/21 Nasdaq upgraded to Buy at UBS on robust volume and organic growth trends 01/19/21 UBS Nasdaq upgraded to Buy from Neutral at UBS NDAQ NDAQ Nasdaq $144.20 / +6.15 (+4.45%) 01/27/21 Nasdaq reports Q4 adjusted EPS $1.60, consensus $1.45 10/21/20 Nasdaq reports Q3 adj. EPS $1.58, consensus $1.45 HOOD NDAQ HOOD Robinhood $0.00 / + (+0.00%) 02/16/21 Robinhood CEO admits communication failure to podcast 'All-In' 02/09/21 Robinhood sued for wrongful death of 20-year-old customer, CNBC reports 02/08/21 Robinhood still plans to go public in 1H21, WSJ reports 02/05/21 Robinhood removes trading restrictions on GameStop, others, Reuters reports NDAQ Nasdaq $144.20 / +6.15 (+4.45%) 02/12/21 Senate Republicans urge SEC to reject Nasdaq diversity rules, Reuters reports 09/29/20 Wall Street data pricing new target for Trump antitrust cop, Bloomberg says 09/29/20 DOJ's Delrahim 'paying close attention' to exchange data pricing, Bloomberg says 09/23/20 Nasdaq, CME plan to launch water futures contract this year, WSJ reports HOOD NDAQ HOOD Robinhood $0.00 / + (+0.00%) 02/05/21 Fly Intel: Wall Street's top stories for Friday 02/02/21 Game On: Wedbush's Pachter talks GameStop volatility, short selling NDAQ Nasdaq $144.20 / +6.15 (+4.45%) 11/19/20 Fly Intel: Wall Street's top stories for Thursday 11/19/20 Morgan Stanley sees needed AML fix potentially slowing Square's Cash App growth 11/19/20 Fly Intel: Wall Street's top stories at midday 11/19/20 Fly Intel: Pre-market Movers 03/11/21 2021 Consumer, Industrials, & TMT Investor Virtual Conference NDAQ NDAQ Nasdaq $144.20 / +6.15 (+4.45%) 12/07/20 Early notable gainers among liquid option names on December 7th
Recommendations	ProsiebenSat price target raised to EUR 17.50 from EUR 15 at Barclays » 14:57 03/05/21 03/05 14:57 03/05/21 14:57 PBSFY ProsiebenSat $0.00 / + (+0.00%) Barclays analyst Julien… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research PBSFY ProsiebenSat $0.00 / + (+0.00%) 14:43 Today Credit Suisse ProsiebenSat price target raised to EUR 9.70 from EUR 8 at Credit Suisse 14:01 Today UBS ProsiebenSat price target raised to EUR 22 from EUR 16 at UBS 13:15 Today Societe Generale ProsiebenSat price target raised to EUR 24 from EUR 20 at Societe Generale 03/01/21 Deutsche Bank ProsiebenSat price target raised to EUR 22 from EUR 14 at Deutsche Bank
Recommendations	Kuehne & Nagel price target raised to CHF 180 from CHF 175 at Barclays » 14:56 03/05/21 03/05 14:56 03/05/21 14:56 KHNGY Kuehne & Nagel $0.00 / + (+0.00%) Barclays analyst Mark… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research KHNGY Kuehne & Nagel $0.00 / + (+0.00%) 14:08 Today Morgan Stanley Kuehne & Nagel price target raised to CHF 200 from CHF 197 at Morgan Stanley 03/04/21 Credit Suisse Kuehne & Nagel price target raised to CHF 187 from CHF 166 at Credit Suisse 03/04/21 AlphaValue Kuehne & Nagel upgraded to Add from Sell at AlphaValue 02/23/21 Bernstein Kuehne & Nagel upgraded to Outperform from Market Perform at Bernstein
Recommendations	Edenred price target raised to EUR 48 from EUR 41.50 at Barclays » 14:55 03/05/21 03/05 14:55 03/05/21 14:55 EDNMY Edenred $0.00 / + (+0.00%) Barclays analyst Paul… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research EDNMY Edenred $0.00 / + (+0.00%) 01/13/21 HSBC Edenred downgraded to Hold from Buy at HSBC 01/12/21 JPMorgan Edenred price target raised to EUR 54 from EUR 47 at JPMorgan 01/08/21 Morgan Stanley Edenred price target raised to EUR 48 from EUR 44 at Morgan Stanley 12/15/20 Deutsche Bank Edenred price target raised to EUR 46.50 from EUR 45.40 at Deutsche Bank
Recommendations	Lufthansa price target raised to EUR 6.20 from EUR 6.10 at Barclays » 14:54 03/05/21 03/05 14:54 03/05/21 14:54 DLAKY Lufthansa $0.00 / + (+0.00%) Barclays analyst Rishika… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Earnings Periodicals DLAKY Lufthansa $0.00 / + (+0.00%) 14:34 Today Deutsche Bank Lufthansa price target raised to EUR 7.20 from EUR 7 at Deutsche Bank 02/18/21 Societe Generale Lufthansa price target raised to EUR 6 from EUR 3 at Societe Generale 01/27/21 Berenberg Lufthansa price target raised to EUR 6.50 from EUR 6 at Berenberg 01/20/21 Barclays Lufthansa price target raised to EUR 6.10 from EUR 5.10 at Barclays DLAKY Lufthansa $0.00 / + (+0.00%) 10/20/20 Lufthansa sees Q3 adj. EBIT loss EUR1.26B vs. profit EUR1.30B last year DLAKY Lufthansa $0.00 / + (+0.00%) 02/15/21 Lufthansa trying to swap orders to smaller jets, Bloomberg reports 12/22/20 Germany extends U.K. travel ban to January 6, Sky News reports 10/05/20 Lufthansa CEO says airline far from breaking even, Reuters reports

Recommendations	BT Group price target lowered to 170 GBp from 180 GBp at Barclays » 14:53 03/05/21 03/05 14:53 03/05/21 14:53 BTGOF BT Group $0.00 / + (+0.00%) Barclays analyst Maurice… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research BTGOF BT Group $0.00 / + (+0.00%) 14:39 Today Credit Suisse BT Group price target raised to 200 GBp from 190 GBp at Credit Suisse 02/10/21 Morgan Stanley BT Group price target raised to 125 GBp from 115 GBp at Morgan Stanley 01/19/21 Berenberg BT Group price target raised to 165 GBp from 155 GBp at Berenberg 01/18/21 UBS BT Group downgraded to Sell from Neutral at UBS
Recommendations	Anglo American price target raised to 3,600 GBp from 2,820 GBp at Barclays » 14:53 03/05/21 03/05 14:53 03/05/21 14:53 NGLOY Anglo American $0.00 / + (+0.00%) Barclays analyst Ian… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Periodicals NGLOY Anglo American $0.00 / + (+0.00%) 14:11 Today JPMorgan Anglo American price target raised to 3,400 GBp from 3,000 GBp at JPMorgan 03/01/21 Berenberg Anglo American price target raised to 3,200 GBp from 3,100 GBp at Berenberg 02/26/21 Deutsche Bank Anglo American price target raised to 3,500 GBp from 3,000 GBp at Deutsche Bank 02/25/21 Berenberg Anglo American price target raised to 3,100 GBp from 2,800 GBp at Berenberg NGLOY Anglo American $0.00 / + (+0.00%) 10/14/20 Anglo American to slash 100 jobs from Grosvenor mine in Queensland, ABC says
Options	Ebang International options imply 27.3% move in share price post-earnings » 14:49 03/05/21 03/05 14:49 03/05/21 14:49 EBON Ebang $5.70 / -0.2 (-3.39%) Pre-earnings options… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Syndicate On The Fly Options EBON Ebang $5.70 / -0.2 (-3.39%) 02/17/21 Ebang to launch bitcoin mining business 02/04/21 Ebang completes chip design for simultaneous LTC, Dogecoin mining 12/31/20 Ebang jumps 25% to $6.13 after announcing launch of cryptocurrency exchange 12/31/20 Ebang to launch cryptocurrency exchange in 1Q21 26 Jun EBON Ebang $5.70 / -0.2 (-3.39%) 02/17/21 Fly Intel: Wall Street's top stories for Wednesday 02/17/21 Fly Intel: Wall Street's top stories at midday 12/31/20 Fly Intel: Wall Street's top stories at midday 12/31/20 Fly Intel: Pre-market Movers EBON Ebang $5.70 / -0.2 (-3.39%) 03/02/21 Largest borrow rate increases among liquid names 02/26/21 Ebang International options imply 20.9% move in share price post-earnings 02/25/21 Largest borrow rate increases among liquid names 02/22/21 Ebang International options imply 48.3% move in share price post-earnings
Recommendations	Lindt & Sprungli price target raised to CHF 8,400 from CHF 8,100 at Berenberg » 14:47 03/05/21 03/05 14:47 03/05/21 14:47 LDSVF Lindt & Sprungli $0.00 / + (+0.00%) Berenberg analyst James… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research LDSVF Lindt & Sprungli $0.00 / + (+0.00%) 03/03/21 Credit Suisse Lindt & Sprungli price target raised to CHF 7,700 at Credit Suisse 01/08/21 Barclays Lindt & Sprungli price target lowered to CHF 74,000 from CHF 75,000 at Barclays 12/16/20 Morgan Stanley Lindt & Sprungli price target raised to CHF 94,372 at Morgan Stanley 12/09/20 Kepler Cheuvreux Lindt & Sprungli upgraded to Hold from Reduce at Kepler Cheuvreux
Recommendations	CaixaBank price target raised to EUR 2.45 from EUR 1.85 at Berenberg » 14:46 03/05/21 03/05 14:46 03/05/21 14:46 CAIXY CaixaBank $0.00 / + (+0.00%) Berenberg analyst Michael… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals CAIXY CaixaBank $0.00 / + (+0.00%) 09/18/20 CaixaBank to acquire Bankia for exchange ratio of 0.6845 shares CAIXY CaixaBank $0.00 / + (+0.00%) 02/22/21 JPMorgan CaixaBank price target raised to EUR 2.65 from EUR 2.35 at JPMorgan 02/03/21 Barclays CaixaBank price target raised to EUR 2.70 from EUR 2.60 at Barclays 02/01/21 Credit Suisse CaixaBank price target raised to EUR 2.70 from EUR 2.60 at Credit Suisse 01/27/21 Citi CaixaBank price target raised to EUR 2.20 from EUR 2.15 at Citi CAIXY CaixaBank $0.00 / + (+0.00%) 09/17/20 Caixabank, Bankia boards approve merger agreement, Reuters reports

Recommendations	Alcon price target raised to CHF 74 from CHF 70 at Berenberg » 14:45 03/05/21 03/05 14:45 03/05/21 14:45 ALC Alcon $67.78 / +0.74 (+1.10%) Berenberg analyst Scott… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly ALC Alcon $67.78 / +0.74 (+1.10%) 01/20/21 Alcon launches PRECISION1 contact lens in the U.S. 11/10/20 Alcon not providing FY20 guidance ALC Alcon $67.78 / +0.74 (+1.10%) 02/26/21 Societe Generale Alcon upgraded to Hold from Sell at Societe Generale 02/25/21 Credit Suisse Alcon price target raised to $86 from $76 at Credit Suisse 01/20/21 Berenberg Alcon price target raised to CHF 70 from CHF 69 at Berenberg 01/07/21 KeyBanc Veeva initiated with an Overweight at KeyBanc ALC Alcon $67.78 / +0.74 (+1.10%) 11/10/20 Alcon reports Q3 EPS 39c, consensus 22c ALC Alcon $67.78 / +0.74 (+1.10%) 11/10/20 Fly Intel: After-Hours Movers
General news	Raphael Bostic Speech to be released at 15:00 14:45 03/05/21 03/05 14:45 03/05/21 14:45
General news	Consumer Credit Month over Month to be reported at 15:00 » 14:45 03/05/21 03/05 14:45 03/05/21 14:45 January Consumer Credit… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Recommendations	GEA Group price target raised to EUR 29 from EUR 27 at Credit Suisse » 14:44 03/05/21 03/05 14:44 03/05/21 14:44 GEAGY GEA Group $0.00 / + (+0.00%) Credit Suisse analyst Max… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research GEAGY GEA Group $0.00 / + (+0.00%) 14:35 Today Deutsche Bank GEA Group price target raised to EUR 29 from EUR 27 at Deutsche Bank 14:07 Today Morgan Stanley GEA Group price target raised to EUR 31 from EUR 29 at Morgan Stanley 01/15/21 Morgan Stanley GEA Group price target raised to EUR 29 from EUR 28 at Morgan Stanley 01/12/21 Deutsche Bank GEA Group price target raised to EUR 27 from EUR 26 at Deutsche Bank
Recommendations	Thales price target raised to EUR 92 from EUR 90 at Credit Suisse » 14:44 03/05/21 03/05 14:44 03/05/21 14:44 THLLY Thales $0.00 / + (+0.00%) Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research THLLY Thales $0.00 / + (+0.00%) 02/11/21 Morgan Stanley Thales price target raised to EUR 91 from EUR 69 at Morgan Stanley 02/08/21 Barclays Thales initiated with an Equal Weight at Barclays 01/26/21 Exane BNP Paribas Thales upgraded to Outperform from Neutral at Exane BNP Paribas 01/15/21 JPMorgan Thales price target raised to EUR 97 from EUR 95 at JPMorgan

Recommendations	ProsiebenSat price target raised to EUR 9.70 from EUR 8 at Credit Suisse » 14:43 03/05/21 03/05 14:43 03/05/21 14:43 PBSFY ProsiebenSat $0.00 / + (+0.00%) Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research PBSFY ProsiebenSat $0.00 / + (+0.00%) 14:01 Today UBS ProsiebenSat price target raised to EUR 22 from EUR 16 at UBS 13:15 Today Societe Generale ProsiebenSat price target raised to EUR 24 from EUR 20 at Societe Generale 03/01/21 Deutsche Bank ProsiebenSat price target raised to EUR 22 from EUR 14 at Deutsche Bank 03/01/21 Morgan Stanley ProsiebenSat price target raised to EUR 12 from EUR 10 at Morgan Stanley
Recommendations	Vifor Pharma price target lowered to CHF 144 from CHF 149 at Credit Suisse » 14:43 03/05/21 03/05 14:43 03/05/21 14:43 GNHAY Vifor Pharma $0.00 / + (+0.00%) Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research GNHAY Vifor Pharma $0.00 / + (+0.00%) 03/04/21 JPMorgan Vifor Pharma price target lowered to CHF 120 from CHF 130 at JPMorgan 03/04/21 Deutsche Bank Vifor Pharma price target lowered to CHF 125 from CHF 150 at Deutsche Bank
Recommendations	Schroders price target raised to 3,270 GBp from 3,100 GBp at Credit Suisse » 14:41 03/05/21 03/05 14:41 03/05/21 14:41 SHNWF Schroders $0.00 / + (+0.00%) Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research SHNWF Schroders $0.00 / + (+0.00%) 14:31 Today JPMorgan Schroders price target raised to 3,400 GBp from 3,375 GBp at JPMorgan 14:02 Today UBS Schroders price target raised to 4,100 GBp from 3,950 GBp at UBS 02/26/21 Morgan Stanley Schroders upgraded to Equal Weight from Underweight at Morgan Stanley 02/22/21 Barclays Schroders price target raised to 3,400 GBp from 2.920 GBp at Barclays
Recommendations	Evonik price target raised to EUR 24 from EUR 22.50 at Credit Suisse » 14:41 03/05/21 03/05 14:41 03/05/21 14:41 EVKIF Evonik $0.00 / + (+0.00%) Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research EVKIF Evonik $0.00 / + (+0.00%) 12/07/20 Durect to sell Lactel product line to Evonik for $15M EVKIF Evonik $0.00 / + (+0.00%) 02/03/21 Barclays Evonik price target raised to EUR 30 from EUR 27 at Barclays 02/02/21 Baader Helvea Evonik downgraded to Add from Buy at Baader Helvea 01/20/21 HSBC Evonik downgraded to Reduce from Hold at HSBC 01/12/21 Morgan Stanley Evonik price target lowered to EUR 30 from EUR 31 at Morgan Stanley
Recommendations	CRH price target raised to EUR 46 from EUR 43 at Credit Suisse » 14:40 03/05/21 03/05 14:40 03/05/21 14:40 CRH CRH $45.91 / -0.35 (-0.76%) Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals CRH CRH $45.91 / -0.35 (-0.76%) 09/21/20 Ash Grove to upgrade import terminal in Florida CRH CRH $45.91 / -0.35 (-0.76%) 14:07 Today Morgan Stanley CRH price target raised to EUR 41 from EUR 40 at Morgan Stanley 02/02/21 JPMorgan CRH price target raised to EUR 43 from EUR 41 at JPMorgan 01/20/21 Barclays CRH price target raised to EUR 35 from EUR 32 at Barclays 01/20/21 UBS CRH price target raised to 3,600 GBp from 3,450 GBp at UBS CRH CRH $45.91 / -0.35 (-0.76%) 12/23/20 HeidelbergCement working to sell California operations, Bloomberg reports

Events

Earnings calls, analyst events, roadshows and more

INFU
2021-03-08 at 00:00

InfuSystem - INFU Conference Calls
2021-03-08 at 00:00

Global Property Virtual Conference Conferences

Virtual Conference
2021-03-08 at 00:00

Media, Internet and Telecom Virtual Conference Conferences

Virtual Conference
INBX
2021-03-08 at 00:00

Inhibrx Firm Sponsored Meetings

Virtual Meeting
TCRR
2021-03-08 at 00:00

TCR2 Therapeutics Firm Sponsored Meetings

Virtual Meeting
TNDM
2021-03-08 at 00:00

Tandem Diabetes Firm Sponsored Meetings

Virtual Meeting
KRP
2021-03-08 at 00:00

Kimbell Royalty Partners Firm Sponsored Meetings

Virtual Meeting
PBH
2021-03-08 at 00:00

Prestige Consumer Firm Sponsored Meetings

Virtual Meeting
IDYA
2021-03-08 at 00:00

Ideaya Biosciences Firm Sponsored Meetings

Virtual Meeting
RGEN
2021-03-08 at 00:00

Repligen Firm Sponsored Meetings

Virtual Meeting

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	SWTX X SWTX SpringsWorks Therapeutics Block Trade Managers: Morgan Stanley Priced at: $84.00 1.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VRT X VRT Vertiv Holdings Block Trade Managers: JPMorgan Priced at: $20.70 17.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs & JPMorgan Priced at: $120.00 2.08M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYNH X SYNH Syneos Health Secondary Managers: Goldman Sachs Priced at: $74.95 7M Shares EAF X EAF GrafTech Spot Secondary Managers: Morgan Stanley Priced at: $11.88 30M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FRC X FRC First Republic Spot Secondary Managers: BofA, JPMorgan & Morgan Stanley Priced at: $166.50 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HLNE X HLNE Hamilton Lane Spot Secondary Managers: JPMorgan Priced at: $88.25 1.45M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial JELD X JELD Jeld-Wen Spot Secondary Managers: Goldman Sachs Priced at: $29.25 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RCL X RCL Royal Caribbean Spot Secondary Managers: Morgan Stanley Priced at: $91.00 16.938M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SITC X SITC Site Centers Spot Secondary Managers: Morgan Stanley & Wells Fargo Priced at: $13.20 15M Shares WSC X WSC WillScot Mobile Mini Spot Secondary Managers: Morgan Stanley Priced at: $27.20 12.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	OSCR X OSCR Oscar Health IPO Managers: Goldman Sachs, Morgan Stanley & Allen & Co., Wells Fargo, Credit Suisse, BofA, Cowen, LION, Ramirez, SIEB Priced at: $39.00 31M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ASLN X ASLN Aslan Pharmaceuticals Secondary Managers: Jefferies & Piper Sandler Priced at: $4.00 15M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CDLX X CDLX Cardlytics Secondary Managers: BofA, JPMorgan, Wells Fargo & Raymond James Priced at: $130.00 3.85M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HSKA X HSKA Heska Secondary Managers: JPMorgan & Piper Sandler Priced at: $186.00 941K Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INDT X INDT Indus Realty Trust Secondary Managers: Morgan Stanley, Citi & Baird, BTIG, JMP Securities, JPMorgan Priced at: $60.00 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MORF X MORF Morphic Secondary Managers: Jefferies, Cowen, BMO Capital & RBC Capital Priced at: $70.00 3.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ICAD X ICAD iCAD Spot Secondary Managers: Guggenheim Priced at: $18.00 1.222M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MGY X MGY Magnolia Oil & Gas Spot Secondary Managers: Credit Suisse & Citi Priced at: $10.50 17M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ORC X ORC Orchid Island Capital Spot Secondary Managers: JPMorgan Priced at: $5.55 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PLXP X PLXP PLx Pharma Spot Secondary Managers: Raymond James & Oppenheimer Priced at: $8.00 7.88M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RDHL X RDHL RedHill Biopharma Spot Secondary Managers: H.C. Wainwright Priced at: $8.00 4.375M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SSYS X SSYS Stratasys Spot Secondary Managers: JPMorgan & Stifel Priced at: $29.00 6.897M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	EYE X EYE National Vision Block Trade Managers: JPMorgan Priced at: $46.50 3.9M Shares INNV X INNV InnovAge IPO Managers: JPMorgan, Barclays, Goldman Sachs & Citi, Baird, William Blair, Piper Sandler, Capital One, Loop Capital, SIEB, Roberts & Ryans Priced at: $21.00 16.667M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AMRK X AMRK A-Mark Precious Metals Secondary Managers: DA Davidson & Roth Capital, CIBC Priced at: $28.00 2.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial COHU X COHU Cohu Secondary Managers: Citi, Goldman Sachs & Stifel, B. Riley Securities, Craig-Hallum, DA Davidson Priced at: $41.00 4.95M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DGII X DGII Digi International Secondary Managers: Piper Sandler Priced at: $19.50 3.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SLQT X SLQT SelectQuote Secondary Managers: Credit Suisse, Morgan Stanley, Goldman Sachs, RBC Capital, Barclays, Citi, Evercore ISI & Jefferies, Cantor Fitzgerald, Keefe Bruyette, Piper Sandler, Drexel Hamilton Priced at: $27.50 10.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SLRX X SLRX Salarius Pharmaceuticals Secondary Managers: Ladenburg Priced at: $1.3685 14.615M Shares VICI X VICI VICI Properties Secondary Managers: Morgan Stanley, BofA, Citi & Deutsche Bank Priced at: $29.00 60M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DX X DX Dynex Capital Spot Secondary Managers: JPMorgan & JMP Securities Priced at: $18.35 3.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LASR X LASR nLight Spot Secondary Managers: Stifel & Raymond James Priced at: $34.00 2.206M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RADA X RADA Rada Electronic Spot Secondary Managers: Jefferies, Baird & Canaccord, AGPR Priced at: $11.50 4.35M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial STX X STX Seagate Spot Secondary Managers: JPMorgan Priced at: $73.25 4.65M Shares
Thurs	NRIX X NRIX Nurix Therapeutics Secondary Managers: JPMorgan, Piper Sandler & Stifel, RBC Capital, Needham Priced at: $31.00 4.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SUI X SUI Sun Communities Secondary Managers: Citi, BofA, BMO Capital, JPMorgan & RBC Capital Priced at: $140.00 7M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AMRC X AMRC Ameresco Spot Secondary Managers: BofA & Oppenheimer, Baird, Canaccord, Guggenheim, William Blair Priced at: $44.00 3.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	NCLH X NCLH Norwegian Cruise Line Spot Secondary Managers: Goldman Sachs Priced at: $29.85 47.6M Shares

Mon	No deals
Tues	No deals
Wed	FVRR X FVRR Fiverr Secondary Managers: JPMorgan, Goldman Sachs, Morgan Stanley $279.44 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Molecular Templates files to sell common stock, no amount given

TODAY'S FREE FLY STORIES

Get Full Fly Access